Fortress Biotech (FBIO) Times Interest Earned (2010 - 2026)
Fortress Biotech (FBIO) posted quarterly Times Interest Earned of -$1.58 for Q4 2025, up 58.99% year-over-year from -$0.99 in Q4 2024, and up 36.39% quarter-over-quarter from -$2.48 in Q3 2025.
Powered by 
Analysis
Fortress Biotech (FBIO) Times Interest Earned (2010 - 2026) Analysis & Trends
Fortress Biotech's Times Interest Earned history runs 16 years deep, the most recent figure standing at -$1.58 for Q4 2025.
- In Q4 2025, Times Interest Earned rose 58.99% year-over-year to -$1.58; the TTM figure through Dec 2025 stood at -$3.87 (up 39.86% YoY), while the FY2025 annual figure was -$0.24, up 18.24% from the prior year.
- Times Interest Earned for Q4 2025 stood at -$1.58, up from -$2.48 in the prior quarter.
- The five-year high for Times Interest Earned was $25.05 in Q4 2021, with the low at -$104.66 in Q4 2022.
- The 5-year median for Times Interest Earned is -$11.3 (2021), against an average of -$13.21.
- The sharpest annual moves came in 2021 and 2022: Times Interest Earned surged 325.12% in 2021, then plunged 517.8% in 2022.
- Fortress Biotech's Times Interest Earned stood at $25.05 in 2021, then plunged by 517.8% to -$104.66 in 2022, then soared by 90.9% to -$9.52 in 2023, then soared by 59.54% to -$3.85 in 2024, then surged by 58.99% to -$1.58 in 2025.
- Business Quant data shows FBIO's Times Interest Earned at -$1.58 in Q4 2025, -$2.48 in Q3 2025, and -$11.36 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 1.42 |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | -0.08 |
| 10 | Fortress Biotech | 86.15 Mn | -110.42 Mn | 12.58 Mn | -6.78 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6.78 |
| Dec 31, 2025 | -2.35 |
| Sep 30, 2025 | -2.48 |
| Jun 30, 2025 | -14.48 |
| Mar 31, 2025 | -7.96 |
| Dec 31, 2024 | -9.19 |
| Sep 30, 2024 | -3.56 |
| Jun 30, 2024 | -13.10 |
| Mar 31, 2024 | -14.05 |
| Dec 31, 2023 | -9.52 |
| Sep 30, 2023 | -5.43 |
| Jun 30, 2023 | -7.80 |
| Mar 31, 2023 | -13.70 |
| Dec 31, 2022 | -11.51 |
| Sep 30, 2022 | -14.95 |
| Jun 30, 2022 | -16.15 |
| Mar 31, 2022 | -20.11 |
| Dec 31, 2021 | -10.48 |
| Sep 30, 2021 | -11.23 |
| Jun 30, 2021 | -15.53 |